nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—TOP2A—prostate cancer	0.115	0.291	CbGaD
Norfloxacin—CYP3A5—prostate cancer	0.091	0.23	CbGaD
Norfloxacin—CYP2A6—prostate cancer	0.0881	0.223	CbGaD
Norfloxacin—CYP1A1—prostate cancer	0.0617	0.156	CbGaD
Norfloxacin—CYP3A4—prostate cancer	0.0394	0.0996	CbGaD
Norfloxacin—TOP2A—Mitoxantrone—prostate cancer	0.0373	0.0955	CbGbCtD
Norfloxacin—TOP2A—Epirubicin—prostate cancer	0.0302	0.0773	CbGbCtD
Norfloxacin—CYP1A1—Flutamide—prostate cancer	0.0297	0.0761	CbGbCtD
Norfloxacin—TOP2A—Etoposide—prostate cancer	0.0235	0.0603	CbGbCtD
Norfloxacin—CYP1A1—Estrone—prostate cancer	0.0215	0.055	CbGbCtD
Norfloxacin—CYP3A5—Flutamide—prostate cancer	0.0178	0.0457	CbGbCtD
Norfloxacin—TOP2A—Doxorubicin—prostate cancer	0.016	0.0411	CbGbCtD
Norfloxacin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.016	0.0409	CbGbCtD
Norfloxacin—CYP1A2—Flutamide—prostate cancer	0.0133	0.034	CbGbCtD
Norfloxacin—CYP3A5—Cabazitaxel—prostate cancer	0.0132	0.0338	CbGbCtD
Norfloxacin—CYP3A5—Estrone—prostate cancer	0.0129	0.033	CbGbCtD
Norfloxacin—CYP1A1—Estradiol—prostate cancer	0.0123	0.0316	CbGbCtD
Norfloxacin—SLC22A6—Conjugated Estrogens—prostate cancer	0.0123	0.0316	CbGbCtD
Norfloxacin—CYP3A7—Estradiol—prostate cancer	0.00986	0.0253	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00986	0.0253	CbGbCtD
Norfloxacin—CYP1A2—Estrone—prostate cancer	0.00959	0.0246	CbGbCtD
Norfloxacin—CYP3A4—Bicalutamide—prostate cancer	0.00839	0.0215	CbGbCtD
Norfloxacin—CYP3A4—Estramustine—prostate cancer	0.0078	0.02	CbGbCtD
Norfloxacin—CYP3A5—Estradiol—prostate cancer	0.0074	0.019	CbGbCtD
Norfloxacin—CYP3A4—Abiraterone—prostate cancer	0.00695	0.0178	CbGbCtD
Norfloxacin—CYP3A4—Flutamide—prostate cancer	0.00695	0.0178	CbGbCtD
Norfloxacin—CYP1A2—Conjugated Estrogens—prostate cancer	0.00627	0.0161	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00589	0.0151	CbGbCtD
Norfloxacin—CYP3A7—Docetaxel—prostate cancer	0.00589	0.0151	CbGbCtD
Norfloxacin—CYP1A2—Estradiol—prostate cancer	0.00551	0.0141	CbGbCtD
Norfloxacin—CYP3A4—Cabazitaxel—prostate cancer	0.00514	0.0132	CbGbCtD
Norfloxacin—CYP3A4—Estrone—prostate cancer	0.00502	0.0129	CbGbCtD
Norfloxacin—CYP3A5—Etoposide—prostate cancer	0.00483	0.0124	CbGbCtD
Norfloxacin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00448	0.0115	CbGbCtD
Norfloxacin—CYP3A5—Docetaxel—prostate cancer	0.00442	0.0113	CbGbCtD
Norfloxacin—CYP1A2—Etoposide—prostate cancer	0.0036	0.00922	CbGbCtD
Norfloxacin—CYP3A4—Conjugated Estrogens—prostate cancer	0.00329	0.00842	CbGbCtD
Norfloxacin—CYP3A4—Mitoxantrone—prostate cancer	0.00299	0.00766	CbGbCtD
Norfloxacin—CYP3A4—Estradiol—prostate cancer	0.00289	0.00739	CbGbCtD
Norfloxacin—CYP3A4—Prednisone—prostate cancer	0.00248	0.00636	CbGbCtD
Norfloxacin—CYP3A4—Etoposide—prostate cancer	0.00188	0.00483	CbGbCtD
Norfloxacin—CYP3A4—Docetaxel—prostate cancer	0.00172	0.00442	CbGbCtD
Norfloxacin—CYP3A4—Doxorubicin—prostate cancer	0.00128	0.00329	CbGbCtD
Norfloxacin—CYP1A2—urine—prostate cancer	0.000925	0.123	CbGeAlD
Norfloxacin—TOP2A—prostate gland—prostate cancer	0.000692	0.0922	CbGeAlD
Norfloxacin—CYP3A4—urine—prostate cancer	0.00067	0.0892	CbGeAlD
Norfloxacin—TOP2A—Docetaxel—Cabazitaxel—prostate cancer	0.000642	0.267	CbGdCrCtD
Norfloxacin—CYP2A6—prostate gland—prostate cancer	0.000632	0.0842	CbGeAlD
Norfloxacin—Trovafloxacin—TOP2A—prostate cancer	0.000624	0.213	CrCbGaD
Norfloxacin—CYP2A6—seminal vesicle—prostate cancer	0.000535	0.0713	CbGeAlD
Norfloxacin—Moxifloxacin—TOP2A—prostate cancer	0.000473	0.161	CrCbGaD
Norfloxacin—TOP2A—Paclitaxel—Cabazitaxel—prostate cancer	0.000443	0.184	CbGdCrCtD
Norfloxacin—SLC22A5—prostate gland—prostate cancer	0.000367	0.0488	CbGeAlD
Norfloxacin—TOP2A—bone marrow—prostate cancer	0.000357	0.0475	CbGeAlD
Norfloxacin—Pefloxacin—TOP2A—prostate cancer	0.000345	0.118	CrCbGaD
Norfloxacin—Enoxacin—TOP2A—prostate cancer	0.000323	0.11	CrCbGaD
Norfloxacin—CYP3A5—prostate gland—prostate cancer	0.00032	0.0427	CbGeAlD
Norfloxacin—SLC22A5—seminal vesicle—prostate cancer	0.00031	0.0413	CbGeAlD
Norfloxacin—TOP2A—testis—prostate cancer	0.000305	0.0406	CbGeAlD
Norfloxacin—SLC22A5—renal system—prostate cancer	0.00025	0.0333	CbGeAlD
Norfloxacin—SLC22A5—urethra—prostate cancer	0.000246	0.0327	CbGeAlD
Norfloxacin—Lomefloxacin—TOP2A—prostate cancer	0.000245	0.0835	CrCbGaD
Norfloxacin—CYP1A1—epithelium—prostate cancer	0.000241	0.0321	CbGeAlD
Norfloxacin—CYP1A2—renal system—prostate cancer	0.000226	0.0302	CbGeAlD
Norfloxacin—CYP1A1—renal system—prostate cancer	0.000223	0.0298	CbGeAlD
Norfloxacin—TOP2A—lymph node—prostate cancer	0.000221	0.0295	CbGeAlD
Norfloxacin—CYP1A1—urethra—prostate cancer	0.000219	0.0292	CbGeAlD
Norfloxacin—CYP3A5—renal system—prostate cancer	0.000218	0.0291	CbGeAlD
Norfloxacin—Ofloxacin—TOP2A—prostate cancer	0.000209	0.0714	CrCbGaD
Norfloxacin—Levofloxacin—TOP2A—prostate cancer	0.000209	0.0714	CrCbGaD
Norfloxacin—Ciprofloxacin—TOP2A—prostate cancer	0.000202	0.0689	CrCbGaD
Norfloxacin—TOP2A—Paclitaxel—Docetaxel—prostate cancer	0.000184	0.0765	CbGdCrCtD
Norfloxacin—CYP3A4—renal system—prostate cancer	0.000164	0.0218	CbGeAlD
Norfloxacin—SLC22A5—testis—prostate cancer	0.000162	0.0215	CbGeAlD
Norfloxacin—Ciprofloxacin—CYP3A5—prostate cancer	0.000159	0.0544	CrCbGaD
Norfloxacin—TOP2A—Fulvestrant—Estradiol—prostate cancer	0.000134	0.0558	CbGdCrCtD
Norfloxacin—TOP2A—Podofilox—Etoposide—prostate cancer	0.000118	0.0491	CbGdCrCtD
Norfloxacin—TOP2A—Teniposide—Etoposide—prostate cancer	0.000118	0.0491	CbGdCrCtD
Norfloxacin—TOP2A—Levorphanol—Estrone—prostate cancer	0.000117	0.0487	CbGdCrCtD
Norfloxacin—SLC22A5—lymph node—prostate cancer	0.000117	0.0156	CbGeAlD
Norfloxacin—CYP1A1—lymph node—prostate cancer	0.000105	0.0139	CbGeAlD
Norfloxacin—TOP2A—Levorphanol—Estradiol—prostate cancer	8.88e-05	0.0369	CbGdCrCtD
Norfloxacin—TOP2A—Methyltestosterone—Ethinyl Estradiol—prostate cancer	8.1e-05	0.0337	CbGdCrCtD
Norfloxacin—Levofloxacin—CYP3A4—prostate cancer	7.15e-05	0.0244	CrCbGaD
Norfloxacin—Ciprofloxacin—CYP3A4—prostate cancer	6.9e-05	0.0235	CrCbGaD
Norfloxacin—TOP2A—Daunorubicin—Epirubicin—prostate cancer	6.17e-05	0.0256	CbGdCrCtD
Norfloxacin—TOP2A—Doxorubicin—Epirubicin—prostate cancer	6.17e-05	0.0256	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Epirubicin—prostate cancer	6.17e-05	0.0256	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Doxorubicin—prostate cancer	5.71e-05	0.0237	CbGdCrCtD
Norfloxacin—TOP2A—Epirubicin—Doxorubicin—prostate cancer	5.71e-05	0.0237	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Doxorubicin—prostate cancer	5.71e-05	0.0237	CbGdCrCtD
Norfloxacin—TOP2A—Norethindrone—Ethinyl Estradiol—prostate cancer	5.28e-05	0.022	CbGdCrCtD
Norfloxacin—TOP2A—Levonorgestrel—Ethinyl Estradiol—prostate cancer	4.2e-05	0.0175	CbGdCrCtD
Norfloxacin—Fatigue—Etoposide—prostate cancer	3.87e-05	0.000317	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Epirubicin—prostate cancer	3.87e-05	0.000316	CcSEcCtD
Norfloxacin—Stomatitis—Epirubicin—prostate cancer	3.85e-05	0.000315	CcSEcCtD
Norfloxacin—Jaundice—Epirubicin—prostate cancer	3.85e-05	0.000315	CcSEcCtD
Norfloxacin—Constipation—Etoposide—prostate cancer	3.84e-05	0.000314	CcSEcCtD
Norfloxacin—Conjunctivitis—Epirubicin—prostate cancer	3.84e-05	0.000314	CcSEcCtD
Norfloxacin—Dizziness—Estradiol—prostate cancer	3.83e-05	0.000313	CcSEcCtD
Norfloxacin—Neutropenia—Doxorubicin—prostate cancer	3.83e-05	0.000313	CcSEcCtD
Norfloxacin—Dry mouth—Docetaxel—prostate cancer	3.81e-05	0.000311	CcSEcCtD
Norfloxacin—Arthralgia—Capecitabine—prostate cancer	3.77e-05	0.000308	CcSEcCtD
Norfloxacin—Chest pain—Capecitabine—prostate cancer	3.77e-05	0.000308	CcSEcCtD
Norfloxacin—Myalgia—Capecitabine—prostate cancer	3.77e-05	0.000308	CcSEcCtD
Norfloxacin—Haematuria—Epirubicin—prostate cancer	3.76e-05	0.000308	CcSEcCtD
Norfloxacin—Confusional state—Docetaxel—prostate cancer	3.76e-05	0.000308	CcSEcCtD
Norfloxacin—Anxiety—Capecitabine—prostate cancer	3.76e-05	0.000307	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Doxorubicin—prostate cancer	3.74e-05	0.000306	CcSEcCtD
Norfloxacin—Anaphylactic shock—Docetaxel—prostate cancer	3.73e-05	0.000305	CcSEcCtD
Norfloxacin—Oedema—Docetaxel—prostate cancer	3.73e-05	0.000305	CcSEcCtD
Norfloxacin—Vision blurred—Prednisone—prostate cancer	3.72e-05	0.000304	CcSEcCtD
Norfloxacin—Feeling abnormal—Etoposide—prostate cancer	3.7e-05	0.000303	CcSEcCtD
Norfloxacin—Diarrhoea—Mitoxantrone—prostate cancer	3.69e-05	0.000302	CcSEcCtD
Norfloxacin—Dry mouth—Capecitabine—prostate cancer	3.69e-05	0.000302	CcSEcCtD
Norfloxacin—Vomiting—Estradiol—prostate cancer	3.68e-05	0.000301	CcSEcCtD
Norfloxacin—Agranulocytosis—Epirubicin—prostate cancer	3.68e-05	0.000301	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Etoposide—prostate cancer	3.67e-05	0.0003	CcSEcCtD
Norfloxacin—Thrombocytopenia—Docetaxel—prostate cancer	3.65e-05	0.000299	CcSEcCtD
Norfloxacin—Rash—Estradiol—prostate cancer	3.65e-05	0.000299	CcSEcCtD
Norfloxacin—Drowsiness—Doxorubicin—prostate cancer	3.65e-05	0.000299	CcSEcCtD
Norfloxacin—Dermatitis—Estradiol—prostate cancer	3.65e-05	0.000299	CcSEcCtD
Norfloxacin—Confusional state—Capecitabine—prostate cancer	3.64e-05	0.000298	CcSEcCtD
Norfloxacin—Headache—Estradiol—prostate cancer	3.63e-05	0.000297	CcSEcCtD
Norfloxacin—Agitation—Prednisone—prostate cancer	3.62e-05	0.000296	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	3.62e-05	0.000296	CcSEcCtD
Norfloxacin—Oedema—Capecitabine—prostate cancer	3.61e-05	0.000296	CcSEcCtD
Norfloxacin—Angioedema—Prednisone—prostate cancer	3.6e-05	0.000295	CcSEcCtD
Norfloxacin—Renal failure—Doxorubicin—prostate cancer	3.59e-05	0.000294	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Doxorubicin—prostate cancer	3.58e-05	0.000293	CcSEcCtD
Norfloxacin—Urticaria—Etoposide—prostate cancer	3.57e-05	0.000292	CcSEcCtD
Norfloxacin—Stomatitis—Doxorubicin—prostate cancer	3.56e-05	0.000291	CcSEcCtD
Norfloxacin—Jaundice—Doxorubicin—prostate cancer	3.56e-05	0.000291	CcSEcCtD
Norfloxacin—Anorexia—Docetaxel—prostate cancer	3.56e-05	0.000291	CcSEcCtD
Norfloxacin—Body temperature increased—Etoposide—prostate cancer	3.55e-05	0.00029	CcSEcCtD
Norfloxacin—Abdominal pain—Etoposide—prostate cancer	3.55e-05	0.00029	CcSEcCtD
Norfloxacin—Conjunctivitis—Doxorubicin—prostate cancer	3.55e-05	0.00029	CcSEcCtD
Norfloxacin—Vertigo—Prednisone—prostate cancer	3.54e-05	0.00029	CcSEcCtD
Norfloxacin—Hepatitis—Epirubicin—prostate cancer	3.54e-05	0.00029	CcSEcCtD
Norfloxacin—Thrombocytopenia—Capecitabine—prostate cancer	3.54e-05	0.000289	CcSEcCtD
Norfloxacin—Hypoaesthesia—Epirubicin—prostate cancer	3.53e-05	0.000288	CcSEcCtD
Norfloxacin—Hyperhidrosis—Capecitabine—prostate cancer	3.49e-05	0.000286	CcSEcCtD
Norfloxacin—Haematuria—Doxorubicin—prostate cancer	3.48e-05	0.000285	CcSEcCtD
Norfloxacin—Anorexia—Capecitabine—prostate cancer	3.45e-05	0.000282	CcSEcCtD
Norfloxacin—Nausea—Estradiol—prostate cancer	3.44e-05	0.000282	CcSEcCtD
Norfloxacin—Vomiting—Mitoxantrone—prostate cancer	3.43e-05	0.000281	CcSEcCtD
Norfloxacin—Convulsion—Prednisone—prostate cancer	3.42e-05	0.00028	CcSEcCtD
Norfloxacin—Visual impairment—Epirubicin—prostate cancer	3.42e-05	0.000279	CcSEcCtD
Norfloxacin—Agranulocytosis—Doxorubicin—prostate cancer	3.41e-05	0.000279	CcSEcCtD
Norfloxacin—Rash—Mitoxantrone—prostate cancer	3.4e-05	0.000278	CcSEcCtD
Norfloxacin—Dermatitis—Mitoxantrone—prostate cancer	3.4e-05	0.000278	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.4e-05	0.000278	CcSEcCtD
Norfloxacin—Headache—Mitoxantrone—prostate cancer	3.38e-05	0.000277	CcSEcCtD
Norfloxacin—Insomnia—Docetaxel—prostate cancer	3.38e-05	0.000276	CcSEcCtD
Norfloxacin—Arthralgia—Prednisone—prostate cancer	3.36e-05	0.000275	CcSEcCtD
Norfloxacin—Myalgia—Prednisone—prostate cancer	3.36e-05	0.000275	CcSEcCtD
Norfloxacin—Paraesthesia—Docetaxel—prostate cancer	3.35e-05	0.000274	CcSEcCtD
Norfloxacin—Erythema multiforme—Epirubicin—prostate cancer	3.35e-05	0.000274	CcSEcCtD
Norfloxacin—Anxiety—Prednisone—prostate cancer	3.35e-05	0.000274	CcSEcCtD
Norfloxacin—Dyspnoea—Docetaxel—prostate cancer	3.33e-05	0.000272	CcSEcCtD
Norfloxacin—Somnolence—Docetaxel—prostate cancer	3.32e-05	0.000271	CcSEcCtD
Norfloxacin—Hypersensitivity—Etoposide—prostate cancer	3.31e-05	0.000271	CcSEcCtD
Norfloxacin—Tinnitus—Epirubicin—prostate cancer	3.3e-05	0.00027	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.29e-05	0.000269	CcSEcCtD
Norfloxacin—Dyspepsia—Docetaxel—prostate cancer	3.29e-05	0.000269	CcSEcCtD
Norfloxacin—Hepatitis—Doxorubicin—prostate cancer	3.28e-05	0.000268	CcSEcCtD
Norfloxacin—Insomnia—Capecitabine—prostate cancer	3.27e-05	0.000267	CcSEcCtD
Norfloxacin—Hypoaesthesia—Doxorubicin—prostate cancer	3.26e-05	0.000267	CcSEcCtD
Norfloxacin—Paraesthesia—Capecitabine—prostate cancer	3.25e-05	0.000265	CcSEcCtD
Norfloxacin—Decreased appetite—Docetaxel—prostate cancer	3.25e-05	0.000265	CcSEcCtD
Norfloxacin—Asthenia—Etoposide—prostate cancer	3.22e-05	0.000264	CcSEcCtD
Norfloxacin—Dyspnoea—Capecitabine—prostate cancer	3.22e-05	0.000264	CcSEcCtD
Norfloxacin—Anaphylactic shock—Prednisone—prostate cancer	3.22e-05	0.000263	CcSEcCtD
Norfloxacin—Oedema—Prednisone—prostate cancer	3.22e-05	0.000263	CcSEcCtD
Norfloxacin—Fatigue—Docetaxel—prostate cancer	3.22e-05	0.000263	CcSEcCtD
Norfloxacin—Nausea—Mitoxantrone—prostate cancer	3.21e-05	0.000262	CcSEcCtD
Norfloxacin—Constipation—Docetaxel—prostate cancer	3.19e-05	0.000261	CcSEcCtD
Norfloxacin—Dyspepsia—Capecitabine—prostate cancer	3.18e-05	0.00026	CcSEcCtD
Norfloxacin—Chills—Epirubicin—prostate cancer	3.18e-05	0.00026	CcSEcCtD
Norfloxacin—Pruritus—Etoposide—prostate cancer	3.18e-05	0.00026	CcSEcCtD
Norfloxacin—Visual impairment—Doxorubicin—prostate cancer	3.16e-05	0.000258	CcSEcCtD
Norfloxacin—Decreased appetite—Capecitabine—prostate cancer	3.14e-05	0.000257	CcSEcCtD
Norfloxacin—Fatigue—Capecitabine—prostate cancer	3.12e-05	0.000255	CcSEcCtD
Norfloxacin—Hyperhidrosis—Prednisone—prostate cancer	3.11e-05	0.000255	CcSEcCtD
Norfloxacin—Erythema multiforme—Doxorubicin—prostate cancer	3.1e-05	0.000254	CcSEcCtD
Norfloxacin—Constipation—Capecitabine—prostate cancer	3.09e-05	0.000253	CcSEcCtD
Norfloxacin—Erythema—Epirubicin—prostate cancer	3.09e-05	0.000252	CcSEcCtD
Norfloxacin—Feeling abnormal—Docetaxel—prostate cancer	3.08e-05	0.000252	CcSEcCtD
Norfloxacin—Diarrhoea—Etoposide—prostate cancer	3.07e-05	0.000251	CcSEcCtD
Norfloxacin—Anorexia—Prednisone—prostate cancer	3.07e-05	0.000251	CcSEcCtD
Norfloxacin—Tinnitus—Doxorubicin—prostate cancer	3.06e-05	0.00025	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Docetaxel—prostate cancer	3.05e-05	0.00025	CcSEcCtD
Norfloxacin—Flatulence—Epirubicin—prostate cancer	3.04e-05	0.000249	CcSEcCtD
Norfloxacin—Tension—Epirubicin—prostate cancer	3.03e-05	0.000248	CcSEcCtD
Norfloxacin—Dysgeusia—Epirubicin—prostate cancer	3.02e-05	0.000247	CcSEcCtD
Norfloxacin—Nervousness—Epirubicin—prostate cancer	3e-05	0.000245	CcSEcCtD
Norfloxacin—Back pain—Epirubicin—prostate cancer	2.98e-05	0.000244	CcSEcCtD
Norfloxacin—Feeling abnormal—Capecitabine—prostate cancer	2.98e-05	0.000244	CcSEcCtD
Norfloxacin—Dizziness—Etoposide—prostate cancer	2.97e-05	0.000243	CcSEcCtD
Norfloxacin—Muscle spasms—Epirubicin—prostate cancer	2.97e-05	0.000243	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Capecitabine—prostate cancer	2.96e-05	0.000242	CcSEcCtD
Norfloxacin—Abdominal pain—Docetaxel—prostate cancer	2.95e-05	0.000241	CcSEcCtD
Norfloxacin—Body temperature increased—Docetaxel—prostate cancer	2.95e-05	0.000241	CcSEcCtD
Norfloxacin—Chills—Doxorubicin—prostate cancer	2.94e-05	0.000241	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Prednisone—prostate cancer	2.93e-05	0.00024	CcSEcCtD
Norfloxacin—Insomnia—Prednisone—prostate cancer	2.91e-05	0.000238	CcSEcCtD
Norfloxacin—Vision blurred—Epirubicin—prostate cancer	2.91e-05	0.000238	CcSEcCtD
Norfloxacin—Paraesthesia—Prednisone—prostate cancer	2.89e-05	0.000236	CcSEcCtD
Norfloxacin—Urticaria—Capecitabine—prostate cancer	2.87e-05	0.000235	CcSEcCtD
Norfloxacin—Abdominal pain—Capecitabine—prostate cancer	2.86e-05	0.000234	CcSEcCtD
Norfloxacin—Body temperature increased—Capecitabine—prostate cancer	2.86e-05	0.000234	CcSEcCtD
Norfloxacin—Vomiting—Etoposide—prostate cancer	2.86e-05	0.000234	CcSEcCtD
Norfloxacin—Erythema—Doxorubicin—prostate cancer	2.85e-05	0.000233	CcSEcCtD
Norfloxacin—TOP2A—Methyltestosterone—Prednisone—prostate cancer	2.85e-05	0.0118	CbGdCrCtD
Norfloxacin—Agitation—Epirubicin—prostate cancer	2.84e-05	0.000232	CcSEcCtD
Norfloxacin—Dyspepsia—Prednisone—prostate cancer	2.83e-05	0.000232	CcSEcCtD
Norfloxacin—Rash—Etoposide—prostate cancer	2.83e-05	0.000232	CcSEcCtD
Norfloxacin—Dermatitis—Etoposide—prostate cancer	2.83e-05	0.000231	CcSEcCtD
Norfloxacin—Headache—Etoposide—prostate cancer	2.81e-05	0.00023	CcSEcCtD
Norfloxacin—Flatulence—Doxorubicin—prostate cancer	2.81e-05	0.00023	CcSEcCtD
Norfloxacin—Tension—Doxorubicin—prostate cancer	2.8e-05	0.000229	CcSEcCtD
Norfloxacin—Decreased appetite—Prednisone—prostate cancer	2.8e-05	0.000229	CcSEcCtD
Norfloxacin—Dysgeusia—Doxorubicin—prostate cancer	2.8e-05	0.000229	CcSEcCtD
Norfloxacin—Fatigue—Prednisone—prostate cancer	2.78e-05	0.000227	CcSEcCtD
Norfloxacin—Nervousness—Doxorubicin—prostate cancer	2.77e-05	0.000227	CcSEcCtD
Norfloxacin—Vertigo—Epirubicin—prostate cancer	2.77e-05	0.000227	CcSEcCtD
Norfloxacin—Leukopenia—Epirubicin—prostate cancer	2.76e-05	0.000226	CcSEcCtD
Norfloxacin—Back pain—Doxorubicin—prostate cancer	2.76e-05	0.000226	CcSEcCtD
Norfloxacin—Constipation—Prednisone—prostate cancer	2.75e-05	0.000225	CcSEcCtD
Norfloxacin—Hypersensitivity—Docetaxel—prostate cancer	2.75e-05	0.000225	CcSEcCtD
Norfloxacin—Muscle spasms—Doxorubicin—prostate cancer	2.74e-05	0.000224	CcSEcCtD
Norfloxacin—Palpitations—Epirubicin—prostate cancer	2.73e-05	0.000223	CcSEcCtD
Norfloxacin—Vision blurred—Doxorubicin—prostate cancer	2.69e-05	0.00022	CcSEcCtD
Norfloxacin—Asthenia—Docetaxel—prostate cancer	2.68e-05	0.000219	CcSEcCtD
Norfloxacin—Convulsion—Epirubicin—prostate cancer	2.67e-05	0.000219	CcSEcCtD
Norfloxacin—Nausea—Etoposide—prostate cancer	2.67e-05	0.000218	CcSEcCtD
Norfloxacin—Hypersensitivity—Capecitabine—prostate cancer	2.66e-05	0.000218	CcSEcCtD
Norfloxacin—Feeling abnormal—Prednisone—prostate cancer	2.65e-05	0.000217	CcSEcCtD
Norfloxacin—Pruritus—Docetaxel—prostate cancer	2.64e-05	0.000216	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Prednisone—prostate cancer	2.63e-05	0.000215	CcSEcCtD
Norfloxacin—Arthralgia—Epirubicin—prostate cancer	2.63e-05	0.000215	CcSEcCtD
Norfloxacin—Myalgia—Epirubicin—prostate cancer	2.63e-05	0.000215	CcSEcCtD
Norfloxacin—Chest pain—Epirubicin—prostate cancer	2.63e-05	0.000215	CcSEcCtD
Norfloxacin—Agitation—Doxorubicin—prostate cancer	2.62e-05	0.000215	CcSEcCtD
Norfloxacin—Anxiety—Epirubicin—prostate cancer	2.62e-05	0.000214	CcSEcCtD
Norfloxacin—Asthenia—Capecitabine—prostate cancer	2.59e-05	0.000212	CcSEcCtD
Norfloxacin—Dry mouth—Epirubicin—prostate cancer	2.57e-05	0.00021	CcSEcCtD
Norfloxacin—Vertigo—Doxorubicin—prostate cancer	2.56e-05	0.00021	CcSEcCtD
Norfloxacin—Urticaria—Prednisone—prostate cancer	2.56e-05	0.000209	CcSEcCtD
Norfloxacin—Pruritus—Capecitabine—prostate cancer	2.56e-05	0.000209	CcSEcCtD
Norfloxacin—Leukopenia—Doxorubicin—prostate cancer	2.56e-05	0.000209	CcSEcCtD
Norfloxacin—Diarrhoea—Docetaxel—prostate cancer	2.55e-05	0.000209	CcSEcCtD
Norfloxacin—Body temperature increased—Prednisone—prostate cancer	2.54e-05	0.000208	CcSEcCtD
Norfloxacin—Abdominal pain—Prednisone—prostate cancer	2.54e-05	0.000208	CcSEcCtD
Norfloxacin—Confusional state—Epirubicin—prostate cancer	2.54e-05	0.000208	CcSEcCtD
Norfloxacin—Palpitations—Doxorubicin—prostate cancer	2.52e-05	0.000206	CcSEcCtD
Norfloxacin—Anaphylactic shock—Epirubicin—prostate cancer	2.52e-05	0.000206	CcSEcCtD
Norfloxacin—Oedema—Epirubicin—prostate cancer	2.52e-05	0.000206	CcSEcCtD
Norfloxacin—Convulsion—Doxorubicin—prostate cancer	2.47e-05	0.000202	CcSEcCtD
Norfloxacin—Diarrhoea—Capecitabine—prostate cancer	2.47e-05	0.000202	CcSEcCtD
Norfloxacin—Dizziness—Docetaxel—prostate cancer	2.47e-05	0.000202	CcSEcCtD
Norfloxacin—Thrombocytopenia—Epirubicin—prostate cancer	2.47e-05	0.000202	CcSEcCtD
Norfloxacin—Hyperhidrosis—Epirubicin—prostate cancer	2.43e-05	0.000199	CcSEcCtD
Norfloxacin—Chest pain—Doxorubicin—prostate cancer	2.43e-05	0.000199	CcSEcCtD
Norfloxacin—Myalgia—Doxorubicin—prostate cancer	2.43e-05	0.000199	CcSEcCtD
Norfloxacin—Arthralgia—Doxorubicin—prostate cancer	2.43e-05	0.000199	CcSEcCtD
Norfloxacin—Anxiety—Doxorubicin—prostate cancer	2.42e-05	0.000198	CcSEcCtD
Norfloxacin—Anorexia—Epirubicin—prostate cancer	2.4e-05	0.000196	CcSEcCtD
Norfloxacin—Dizziness—Capecitabine—prostate cancer	2.39e-05	0.000195	CcSEcCtD
Norfloxacin—Dry mouth—Doxorubicin—prostate cancer	2.38e-05	0.000194	CcSEcCtD
Norfloxacin—Vomiting—Docetaxel—prostate cancer	2.37e-05	0.000194	CcSEcCtD
Norfloxacin—Hypersensitivity—Prednisone—prostate cancer	2.37e-05	0.000194	CcSEcCtD
Norfloxacin—Rash—Docetaxel—prostate cancer	2.35e-05	0.000192	CcSEcCtD
Norfloxacin—Dermatitis—Docetaxel—prostate cancer	2.35e-05	0.000192	CcSEcCtD
Norfloxacin—Confusional state—Doxorubicin—prostate cancer	2.35e-05	0.000192	CcSEcCtD
Norfloxacin—Headache—Docetaxel—prostate cancer	2.34e-05	0.000191	CcSEcCtD
Norfloxacin—Anaphylactic shock—Doxorubicin—prostate cancer	2.33e-05	0.000191	CcSEcCtD
Norfloxacin—Oedema—Doxorubicin—prostate cancer	2.33e-05	0.000191	CcSEcCtD
Norfloxacin—Asthenia—Prednisone—prostate cancer	2.31e-05	0.000189	CcSEcCtD
Norfloxacin—Vomiting—Capecitabine—prostate cancer	2.3e-05	0.000188	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.29e-05	0.000188	CcSEcCtD
Norfloxacin—Thrombocytopenia—Doxorubicin—prostate cancer	2.28e-05	0.000187	CcSEcCtD
Norfloxacin—Rash—Capecitabine—prostate cancer	2.28e-05	0.000186	CcSEcCtD
Norfloxacin—Pruritus—Prednisone—prostate cancer	2.28e-05	0.000186	CcSEcCtD
Norfloxacin—Insomnia—Epirubicin—prostate cancer	2.28e-05	0.000186	CcSEcCtD
Norfloxacin—Dermatitis—Capecitabine—prostate cancer	2.28e-05	0.000186	CcSEcCtD
Norfloxacin—Headache—Capecitabine—prostate cancer	2.26e-05	0.000185	CcSEcCtD
Norfloxacin—Paraesthesia—Epirubicin—prostate cancer	2.26e-05	0.000185	CcSEcCtD
Norfloxacin—Hyperhidrosis—Doxorubicin—prostate cancer	2.25e-05	0.000184	CcSEcCtD
Norfloxacin—Dyspnoea—Epirubicin—prostate cancer	2.24e-05	0.000184	CcSEcCtD
Norfloxacin—Somnolence—Epirubicin—prostate cancer	2.24e-05	0.000183	CcSEcCtD
Norfloxacin—Anorexia—Doxorubicin—prostate cancer	2.22e-05	0.000182	CcSEcCtD
Norfloxacin—Nausea—Docetaxel—prostate cancer	2.22e-05	0.000181	CcSEcCtD
Norfloxacin—Dyspepsia—Epirubicin—prostate cancer	2.22e-05	0.000181	CcSEcCtD
Norfloxacin—Diarrhoea—Prednisone—prostate cancer	2.2e-05	0.00018	CcSEcCtD
Norfloxacin—Decreased appetite—Epirubicin—prostate cancer	2.19e-05	0.000179	CcSEcCtD
Norfloxacin—Fatigue—Epirubicin—prostate cancer	2.17e-05	0.000178	CcSEcCtD
Norfloxacin—Constipation—Epirubicin—prostate cancer	2.15e-05	0.000176	CcSEcCtD
Norfloxacin—Nausea—Capecitabine—prostate cancer	2.15e-05	0.000176	CcSEcCtD
Norfloxacin—Dizziness—Prednisone—prostate cancer	2.13e-05	0.000174	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.12e-05	0.000174	CcSEcCtD
Norfloxacin—Insomnia—Doxorubicin—prostate cancer	2.11e-05	0.000172	CcSEcCtD
Norfloxacin—Paraesthesia—Doxorubicin—prostate cancer	2.09e-05	0.000171	CcSEcCtD
Norfloxacin—Dyspnoea—Doxorubicin—prostate cancer	2.08e-05	0.00017	CcSEcCtD
Norfloxacin—Feeling abnormal—Epirubicin—prostate cancer	2.07e-05	0.00017	CcSEcCtD
Norfloxacin—Somnolence—Doxorubicin—prostate cancer	2.07e-05	0.000169	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Epirubicin—prostate cancer	2.06e-05	0.000168	CcSEcCtD
Norfloxacin—Dyspepsia—Doxorubicin—prostate cancer	2.05e-05	0.000168	CcSEcCtD
Norfloxacin—Vomiting—Prednisone—prostate cancer	2.05e-05	0.000167	CcSEcCtD
Norfloxacin—Rash—Prednisone—prostate cancer	2.03e-05	0.000166	CcSEcCtD
Norfloxacin—Dermatitis—Prednisone—prostate cancer	2.03e-05	0.000166	CcSEcCtD
Norfloxacin—Decreased appetite—Doxorubicin—prostate cancer	2.03e-05	0.000166	CcSEcCtD
Norfloxacin—Headache—Prednisone—prostate cancer	2.02e-05	0.000165	CcSEcCtD
Norfloxacin—Fatigue—Doxorubicin—prostate cancer	2.01e-05	0.000164	CcSEcCtD
Norfloxacin—Urticaria—Epirubicin—prostate cancer	2e-05	0.000164	CcSEcCtD
Norfloxacin—Constipation—Doxorubicin—prostate cancer	1.99e-05	0.000163	CcSEcCtD
Norfloxacin—Abdominal pain—Epirubicin—prostate cancer	1.99e-05	0.000163	CcSEcCtD
Norfloxacin—Body temperature increased—Epirubicin—prostate cancer	1.99e-05	0.000163	CcSEcCtD
Norfloxacin—Feeling abnormal—Doxorubicin—prostate cancer	1.92e-05	0.000157	CcSEcCtD
Norfloxacin—Nausea—Prednisone—prostate cancer	1.91e-05	0.000156	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Doxorubicin—prostate cancer	1.91e-05	0.000156	CcSEcCtD
Norfloxacin—Hypersensitivity—Epirubicin—prostate cancer	1.86e-05	0.000152	CcSEcCtD
Norfloxacin—Urticaria—Doxorubicin—prostate cancer	1.85e-05	0.000151	CcSEcCtD
Norfloxacin—Abdominal pain—Doxorubicin—prostate cancer	1.84e-05	0.000151	CcSEcCtD
Norfloxacin—Body temperature increased—Doxorubicin—prostate cancer	1.84e-05	0.000151	CcSEcCtD
Norfloxacin—Asthenia—Epirubicin—prostate cancer	1.81e-05	0.000148	CcSEcCtD
Norfloxacin—Pruritus—Epirubicin—prostate cancer	1.78e-05	0.000146	CcSEcCtD
Norfloxacin—Diarrhoea—Epirubicin—prostate cancer	1.72e-05	0.000141	CcSEcCtD
Norfloxacin—Hypersensitivity—Doxorubicin—prostate cancer	1.72e-05	0.00014	CcSEcCtD
Norfloxacin—Asthenia—Doxorubicin—prostate cancer	1.67e-05	0.000137	CcSEcCtD
Norfloxacin—Dizziness—Epirubicin—prostate cancer	1.67e-05	0.000136	CcSEcCtD
Norfloxacin—Pruritus—Doxorubicin—prostate cancer	1.65e-05	0.000135	CcSEcCtD
Norfloxacin—Vomiting—Epirubicin—prostate cancer	1.6e-05	0.000131	CcSEcCtD
Norfloxacin—Diarrhoea—Doxorubicin—prostate cancer	1.59e-05	0.00013	CcSEcCtD
Norfloxacin—Rash—Epirubicin—prostate cancer	1.59e-05	0.00013	CcSEcCtD
Norfloxacin—Dermatitis—Epirubicin—prostate cancer	1.59e-05	0.00013	CcSEcCtD
Norfloxacin—Headache—Epirubicin—prostate cancer	1.58e-05	0.000129	CcSEcCtD
Norfloxacin—Dizziness—Doxorubicin—prostate cancer	1.54e-05	0.000126	CcSEcCtD
Norfloxacin—Nausea—Epirubicin—prostate cancer	1.5e-05	0.000122	CcSEcCtD
Norfloxacin—Vomiting—Doxorubicin—prostate cancer	1.48e-05	0.000121	CcSEcCtD
Norfloxacin—Rash—Doxorubicin—prostate cancer	1.47e-05	0.00012	CcSEcCtD
Norfloxacin—Dermatitis—Doxorubicin—prostate cancer	1.47e-05	0.00012	CcSEcCtD
Norfloxacin—Headache—Doxorubicin—prostate cancer	1.46e-05	0.000119	CcSEcCtD
Norfloxacin—Nausea—Doxorubicin—prostate cancer	1.38e-05	0.000113	CcSEcCtD
Norfloxacin—CYP3A5—Metabolism—SLC5A5—prostate cancer	3.46e-06	4.37e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NCOA2—prostate cancer	3.43e-06	4.33e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.42e-06	4.33e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTAP—prostate cancer	3.42e-06	4.33e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	3.4e-06	4.3e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP2E1—prostate cancer	3.38e-06	4.27e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TBXAS1—prostate cancer	3.36e-06	4.25e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTA4—prostate cancer	3.36e-06	4.25e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP1A1—prostate cancer	3.36e-06	4.25e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NQO1—prostate cancer	3.34e-06	4.22e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.34e-06	4.22e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.34e-06	4.22e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ERCC2—prostate cancer	3.33e-06	4.21e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TH—prostate cancer	3.29e-06	4.16e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—TYMS—prostate cancer	3.29e-06	4.15e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	3.29e-06	4.15e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTA2—prostate cancer	3.28e-06	4.14e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC5A5—prostate cancer	3.27e-06	4.13e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP3A4—prostate cancer	3.26e-06	4.12e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTM1—prostate cancer	3.25e-06	4.11e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCG5—prostate cancer	3.24e-06	4.09e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SULT1A1—prostate cancer	3.24e-06	4.09e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP1B1—prostate cancer	3.21e-06	4.05e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP2E1—prostate cancer	3.19e-06	4.04e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—LPL—prostate cancer	3.19e-06	4.03e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ACSL4—prostate cancer	3.18e-06	4.02e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.18e-06	4.02e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTA1—prostate cancer	3.16e-06	3.99e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NQO1—prostate cancer	3.16e-06	3.99e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—MTHFR—prostate cancer	3.13e-06	3.96e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTO1—prostate cancer	3.13e-06	3.95e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HSD3B2—prostate cancer	3.13e-06	3.95e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NAT2—prostate cancer	3.13e-06	3.95e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TH—prostate cancer	3.11e-06	3.93e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GGT1—prostate cancer	3.1e-06	3.92e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.09e-06	3.91e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP3A4—prostate cancer	3.08e-06	3.89e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP1A1—prostate cancer	3.08e-06	3.89e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPARA—prostate cancer	3.07e-06	3.88e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.06e-06	3.87e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NCOA1—prostate cancer	3.06e-06	3.86e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ERCC2—prostate cancer	3.05e-06	3.86e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PHGDH—prostate cancer	3.05e-06	3.86e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ARG2—prostate cancer	3.05e-06	3.86e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—UMPS—prostate cancer	3.05e-06	3.86e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP1B1—prostate cancer	3.03e-06	3.83e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP19A1—prostate cancer	3.01e-06	3.81e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3e-06	3.8e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2C18—prostate cancer	3e-06	3.79e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PLCB2—prostate cancer	3e-06	3.79e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—LRP2—prostate cancer	3e-06	3.79e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LDHB—prostate cancer	2.99e-06	3.78e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—P4HB—prostate cancer	2.94e-06	3.71e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.94e-06	3.71e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GGT1—prostate cancer	2.93e-06	3.71e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—RXRA—prostate cancer	2.91e-06	3.68e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CAV1—prostate cancer	2.89e-06	3.65e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NCOA1—prostate cancer	2.89e-06	3.65e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—MTHFR—prostate cancer	2.87e-06	3.63e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC22A1—prostate cancer	2.86e-06	3.61e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP19A1—prostate cancer	2.85e-06	3.6e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TCN2—prostate cancer	2.84e-06	3.58e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PDHA1—prostate cancer	2.84e-06	3.58e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—UCP3—prostate cancer	2.84e-06	3.58e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTA3—prostate cancer	2.84e-06	3.58e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.83e-06	3.57e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARA—prostate cancer	2.82e-06	3.56e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—COMT—prostate cancer	2.8e-06	3.54e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTP1—prostate cancer	2.79e-06	3.52e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SULT2A1—prostate cancer	2.79e-06	3.52e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—RXRA—prostate cancer	2.75e-06	3.47e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ITPR1—prostate cancer	2.74e-06	3.47e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MED12—prostate cancer	2.74e-06	3.46e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GNG5—prostate cancer	2.72e-06	3.44e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.71e-06	3.42e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.71e-06	3.42e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.67e-06	3.38e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CAV1—prostate cancer	2.65e-06	3.35e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—COMT—prostate cancer	2.65e-06	3.34e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTP1—prostate cancer	2.63e-06	3.33e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CG—prostate cancer	2.63e-06	3.33e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NCOA3—prostate cancer	2.62e-06	3.31e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTA4—prostate cancer	2.59e-06	3.28e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.59e-06	3.28e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TYMS—prostate cancer	2.59e-06	3.28e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ITPR1—prostate cancer	2.59e-06	3.28e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.57e-06	3.25e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTM1—prostate cancer	2.56e-06	3.24e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.55e-06	3.22e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTA2—prostate cancer	2.53e-06	3.2e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—LPL—prostate cancer	2.51e-06	3.18e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HPGDS—prostate cancer	2.5e-06	3.16e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCG5—prostate cancer	2.5e-06	3.16e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.5e-06	3.16e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—INS—prostate cancer	2.49e-06	3.15e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2C19—prostate cancer	2.48e-06	3.14e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TYMS—prostate cancer	2.45e-06	3.1e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CREBBP—prostate cancer	2.44e-06	3.08e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTA1—prostate cancer	2.44e-06	3.08e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.43e-06	3.07e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ACHE—prostate cancer	2.42e-06	3.06e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTT1—prostate cancer	2.42e-06	3.06e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTM1—prostate cancer	2.42e-06	3.06e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CG—prostate cancer	2.41e-06	3.05e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.41e-06	3.05e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTO1—prostate cancer	2.41e-06	3.05e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NAT2—prostate cancer	2.41e-06	3.05e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ERCC2—prostate cancer	2.41e-06	3.04e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.4e-06	3.03e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.39e-06	3.02e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—LPL—prostate cancer	2.38e-06	3e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.33e-06	2.94e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PRKACB—prostate cancer	2.32e-06	2.93e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CD—prostate cancer	2.31e-06	2.92e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LRP2—prostate cancer	2.31e-06	2.92e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PLCB2—prostate cancer	2.31e-06	2.92e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.31e-06	2.92e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.29e-06	2.9e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—INS—prostate cancer	2.28e-06	2.89e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ERCC2—prostate cancer	2.28e-06	2.88e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—P4HB—prostate cancer	2.27e-06	2.87e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—MTHFR—prostate cancer	2.26e-06	2.86e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.26e-06	2.86e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CREBBP—prostate cancer	2.24e-06	2.83e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARA—prostate cancer	2.22e-06	2.81e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.21e-06	2.79e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NCOA2—prostate cancer	2.19e-06	2.76e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NOS3—prostate cancer	2.18e-06	2.76e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.15e-06	2.72e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—MTHFR—prostate cancer	2.14e-06	2.7e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CD—prostate cancer	2.12e-06	2.68e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MED12—prostate cancer	2.11e-06	2.67e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARA—prostate cancer	2.1e-06	2.65e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GNG5—prostate cancer	2.1e-06	2.65e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CAV1—prostate cancer	2.09e-06	2.64e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.09e-06	2.64e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.04e-06	2.57e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NCOA3—prostate cancer	2.02e-06	2.55e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CB—prostate cancer	2.02e-06	2.55e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NQO1—prostate cancer	2.01e-06	2.55e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NOS3—prostate cancer	2e-06	2.53e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS2—prostate cancer	2e-06	2.53e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TH—prostate cancer	1.98e-06	2.51e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CAV1—prostate cancer	1.97e-06	2.49e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.97e-06	2.49e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.96e-06	2.48e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.95e-06	2.47e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.93e-06	2.44e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HPGDS—prostate cancer	1.93e-06	2.44e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.92e-06	2.42e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.9e-06	2.4e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.89e-06	2.38e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTT1—prostate cancer	1.87e-06	2.36e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ACHE—prostate cancer	1.87e-06	2.36e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GGT1—prostate cancer	1.87e-06	2.36e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.85e-06	2.34e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CB—prostate cancer	1.85e-06	2.34e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NCOA1—prostate cancer	1.84e-06	2.33e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS2—prostate cancer	1.83e-06	2.31e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.82e-06	2.29e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—INS—prostate cancer	1.8e-06	2.28e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.8e-06	2.27e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CG—prostate cancer	1.8e-06	2.27e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PRKACB—prostate cancer	1.79e-06	2.26e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.77e-06	2.24e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CREBBP—prostate cancer	1.76e-06	2.23e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—RXRA—prostate cancer	1.75e-06	2.21e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTEN—prostate cancer	1.74e-06	2.2e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.7e-06	2.15e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—INS—prostate cancer	1.7e-06	2.15e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—COMT—prostate cancer	1.69e-06	2.13e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NCOA2—prostate cancer	1.69e-06	2.13e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTP1—prostate cancer	1.68e-06	2.12e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.67e-06	2.11e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CREBBP—prostate cancer	1.67e-06	2.11e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—EP300—prostate cancer	1.66e-06	2.1e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ITPR1—prostate cancer	1.65e-06	2.09e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.63e-06	2.05e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.61e-06	2.03e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTEN—prostate cancer	1.6e-06	2.02e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CD—prostate cancer	1.58e-06	2e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NOS3—prostate cancer	1.58e-06	2e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.57e-06	1.99e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TYMS—prostate cancer	1.56e-06	1.97e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NQO1—prostate cancer	1.55e-06	1.96e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTM1—prostate cancer	1.54e-06	1.95e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TH—prostate cancer	1.53e-06	1.94e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—EP300—prostate cancer	1.52e-06	1.93e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—LPL—prostate cancer	1.52e-06	1.91e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NOS3—prostate cancer	1.49e-06	1.89e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.49e-06	1.88e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.46e-06	1.85e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.46e-06	1.84e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ERCC2—prostate cancer	1.45e-06	1.83e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS2—prostate cancer	1.44e-06	1.83e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GGT1—prostate cancer	1.44e-06	1.82e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NCOA1—prostate cancer	1.42e-06	1.8e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.4e-06	1.77e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CB—prostate cancer	1.38e-06	1.74e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS2—prostate cancer	1.36e-06	1.72e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MTHFR—prostate cancer	1.36e-06	1.72e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—RXRA—prostate cancer	1.35e-06	1.71e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARA—prostate cancer	1.34e-06	1.69e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—COMT—prostate cancer	1.3e-06	1.65e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTP1—prostate cancer	1.3e-06	1.64e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ITPR1—prostate cancer	1.28e-06	1.61e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTEN—prostate cancer	1.26e-06	1.59e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CAV1—prostate cancer	1.26e-06	1.59e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.23e-06	1.55e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TYMS—prostate cancer	1.21e-06	1.52e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.2e-06	1.52e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—EP300—prostate cancer	1.2e-06	1.52e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTM1—prostate cancer	1.19e-06	1.51e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTEN—prostate cancer	1.19e-06	1.5e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LPL—prostate cancer	1.17e-06	1.48e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.15e-06	1.45e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—EP300—prostate cancer	1.14e-06	1.43e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.13e-06	1.43e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CA—prostate cancer	1.13e-06	1.42e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ERCC2—prostate cancer	1.12e-06	1.42e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—INS—prostate cancer	1.08e-06	1.37e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CREBBP—prostate cancer	1.06e-06	1.34e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTHFR—prostate cancer	1.05e-06	1.33e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARA—prostate cancer	1.03e-06	1.31e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.01e-06	1.27e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AKT1—prostate cancer	1e-06	1.27e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CAV1—prostate cancer	9.71e-07	1.23e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NOS3—prostate cancer	9.51e-07	1.2e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AKT1—prostate cancer	9.21e-07	1.16e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CA—prostate cancer	8.89e-07	1.12e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CG—prostate cancer	8.85e-07	1.12e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CB—prostate cancer	8.78e-07	1.11e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS2—prostate cancer	8.7e-07	1.1e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CA—prostate cancer	8.4e-07	1.06e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—INS—prostate cancer	8.37e-07	1.06e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CREBBP—prostate cancer	8.2e-07	1.04e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CD—prostate cancer	7.78e-07	9.83e-06	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTEN—prostate cancer	7.59e-07	9.59e-06	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NOS3—prostate cancer	7.34e-07	9.28e-06	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AKT1—prostate cancer	7.26e-07	9.18e-06	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—EP300—prostate cancer	7.24e-07	9.15e-06	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AKT1—prostate cancer	6.86e-07	8.67e-06	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.78e-07	8.57e-06	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS2—prostate cancer	6.72e-07	8.49e-06	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTEN—prostate cancer	5.86e-07	7.4e-06	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—EP300—prostate cancer	5.59e-07	7.06e-06	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CA—prostate cancer	5.35e-07	6.77e-06	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AKT1—prostate cancer	4.37e-07	5.53e-06	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.13e-07	5.22e-06	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKT1—prostate cancer	3.38e-07	4.27e-06	CbGpPWpGaD
